Prognostic impact of BRCA mutation on metastasis-free survival in a localized/locoregional high-risk real-world prostate cancer population.
Frances A. Brito(Tempus Labs (United States)), Sara Dempster(AstraZeneca (United States)), Sajan Khosla(Queen Elizabeth Hospital Birmingham), Rebecca Song(AstraZeneca (United States)), Alan Barnicle(AstraZeneca (United Kingdom)), Jessica J. P. Shami(AstraZeneca (United Kingdom)), David Roy(UNSW Sydney), Aditya Rajan(AstraZeneca (United States)), Jessica Dow(Tempus Labs (United States)), Jimmy L. Zhao(California Institute of Technology)
Cited by 0
Related Papers
Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves
|Circulation|2012|580
Transcatheter Aortic Valve Implantation for Pure Severe Native Aortic Valve Regurgitation
|Journal of the American College of Cardiology|2013|309
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
|The Lancet Rheumatology|2020|153
Malignancy-related mortality following kidney transplantation is common
|Kidney International|2013|149
Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity
|Proceedings of the National Academy of Sciences|2014|133